Showing results (131-140 of 245) with videos related to

Sort By:
Pageof 25
Molecular Therapy Oncolytics|February 4, 2022
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse modelYufei Wang, Alicia Buck, Marion Grimaud, et al.
Science (New York, N.Y.)|August 27, 2016
pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent mannerJianping Guo, Abhishek A Chakraborty, Pengda Liu, et al.
Journal for Immunotherapy of Cancer|March 14, 2015
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré P Fay, Sabina Signoretti, Marcella Callea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor GenesCarla Calagua, Miriam Ficial, Caroline S Jansen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell CarcinomaAndre P Fay, Guillermo de Velasco, Thai H Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse modelYe He, Joshua Rivera, Miklos Diossy, et al.
Cell Reports. Medicine|September 20, 2023
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer statesJackson Nyman, Thomas Denize, Ziad Bakouny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUNAbdallah Flaifel, Wanling Xie, David A Braun, et al.
British Journal of Cancer|April 21, 2018
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinomaGuillermo de Velasco, Stephanie A Wankowicz, Russell Madison, et al.
The Oncologist|February 22, 2017
Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic ModelGuillermo de Velasco, Aedín C Culhane, André P Fay, et al.
Pageof 25